Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis ; volume:13 ; number:1 ; day:14 ; month:11 ; year:2013 ; pages:1-14 ; date:12.2013
BMC cardiovascular disorders ; 13, Heft 1 (14.11.2013), 1-14, 12.2013
- Creator
-
Li-Sha, Ge
- Contributor
-
Yi-He, Chen
Na-Dan, Zhou
Teng, Zhang
Yue-Chun, Li
SpringerLink (Online service)
- DOI
-
10.1186/1471-2261-13-100
- URN
-
urn:nbn:de:1111-2016032613964
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li-Sha, Ge
- Yi-He, Chen
- Na-Dan, Zhou
- Teng, Zhang
- Yue-Chun, Li
- SpringerLink (Online service)
Other Objects (12)
Impact of colchicine on experimental Coxsackievirus B3-induced myocarditis
Impact of cardiac stromal cells on Coxsackievirus B3-induced myocarditis
Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
Myocarditis und Cardiomyopathie : Virusnachweis bei der experimentellen Coxsackievirus B3 Myocarditits und deren Folgekrankheit
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Role of NOD2 and S100A8/S100A9 in the pathogenesis of Coxsackievirus B3-induced myocarditis
IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
The whole genome sequence of Coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis
Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis
Increased Expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis
Impact of colchicine on experimental Coxsackievirus B3-induced myocarditis
Impact of cardiac stromal cells on Coxsackievirus B3-induced myocarditis
Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
Myocarditis und Cardiomyopathie : Virusnachweis bei der experimentellen Coxsackievirus B3 Myocarditits und deren Folgekrankheit
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Role of NOD2 and S100A8/S100A9 in the pathogenesis of Coxsackievirus B3-induced myocarditis
IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
The whole genome sequence of Coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis
Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis
Increased Expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis
Impact of colchicine on experimental Coxsackievirus B3-induced myocarditis
Impact of cardiac stromal cells on Coxsackievirus B3-induced myocarditis
Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
Myocarditis und Cardiomyopathie : Virusnachweis bei der experimentellen Coxsackievirus B3 Myocarditits und deren Folgekrankheit
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Role of NOD2 and S100A8/S100A9 in the pathogenesis of Coxsackievirus B3-induced myocarditis
IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
The whole genome sequence of Coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis
Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis